nach oben

Erschienen in:

25.03.2023 | Review Article

What is the role of brown adipose tissue in metabolic health: lessons learned and future perspectives in the long COVID?

verfasst von: Iryna Muzyka, Oleh Revenko, Iryna Kovalchuk, Maryanna Savytska, Anna Bekesevych, Roksolana Kasko, Oksana Zayachkivska

Erschienen in: Inflammopharmacology | Ausgabe 2/2023

Einloggen, um Zugang zu erhalten

Abstract

Metabolic physiology plays a key role in maintaining our health and resilience. Metabolic disorders can lead to serious illnesses, including obesity. The pathogenesis of the new long COVID syndrome in individuals with long-term recovery after SARS-Co-2 infection is still incomplete. Thus there is growing attention in the study of adipose tissue activities, especially brown adipose tissue (BAT) and associated resilience which plays a crucial role in different types of obesity as potential targets for pharmacologic and nutritional interventions in the context of obesity and long COVID. The number of studies examining mechanisms underlying BAT has grown rapidly in the last 10 years despite of role of BAT in individuals with COVID-19 and long COVID is modest. Therefore, this review aims to sum up data examining BAT activities, its resilience in health, obesity, and the possible link to long COVID. The search was conducted on studies published in English mostly between 2004 and 2022 in adult humans and animal models. Database searches were conducted using PubMed, Scopus, and Google Scholar for key terms including adipose tissue, BAT, adipokines, obesity, VPF/VEGF, and pathogenesis. From the initial search through the database were identified relevant articles that met inclusion and exclusion criteria and our data regarding adipose tissues were presented in this review. It will discuss adiposity tissue activities. Current literature suggests that there are BAT integral effects to whitening and browning fat phenomena which reflect the homeostatic metabolic adaptive ability for environmental demand or survival/adaptive mechanisms. We also review neural and vascular impacts in BAT that play a role in resilience and obesity. Finally, we discuss the role of BAT in the context of long COVID in basic research and clinical research.

Aquila H, Link TA, Klingenberg M (1985) The uncoupling protein from brown fat mitochondria is related to the mitochondrial ADP/ATP carrier. Analysis of sequence homologies and of folding of the protein in the membrane. EMBO J 4(9):2369–2376CrossRefPubMedPubMedCentral

Basolo A, Poma AM, Bonuccelli D, Proietti A, Macerola E, Ugolini C, Torregrossa L, Giannini R, Vignali P, Basolo F, Santini F (2022) Adipose tissue in COVID-19: detection of SARS-CoV-2 in adipocytes and activation of the interferon-alpha response. J Endocrinol Invest 45(5):1021–1029CrossRefPubMedPubMedCentral

Bates R, Huang W, Cao L (2020) Adipose tissue: an emerging target for adeno-associated viral vectors. Mol Ther Methods Clin Dev 20(19):236–249. https://doi.org/10.1016/j.omtm.2020.09.009CrossRef

Bezpalko L, Gavrilyuk O, Zayachkivska O (2015) Inflammatory response in visceral fat tissue and liver is prenatally programmed: experimental research. J Physiol Pharmacol 66(1):57–64 (PMID: 25716965)PubMed

Callard F, Perego E (2021) How and why patients made long Covid. Soc Sci Med 268:113426CrossRefPubMedPubMedCentral

Cannon B, Nedergaard J (2004) Brown adipose tissue: function and physiological significance. Physiol Rev 84(1):277–359. https://doi.org/10.1152/physrev.00015.2003. (PMID: 14715917)CrossRefPubMed

de Lucena TMC, da Silva Santos AF, de Lima BR, de Albuquerque Borborema ME, de Azevêdo Silva J (2020) Mechanism of inflammatory response in associated comorbidities in COVID-19. Diabetes Metab Syndr 14(4):597–600CrossRefPubMedPubMedCentral

Favre G, Legueult K, Pradier C, Raffaelli C, Ichai C, Iannelli A, Esnault V (2021) Visceral fat is associated to the severity of COVID-19. Metabolism 115:154440CrossRefPubMed

Finucane FM, Davenport C (2020) Coronavirus and obesity: could insulin resistance mediate the severity of COVID-19 infection? Front Public Health 8:184CrossRefPubMedPubMedCentral

Frigolet ME, Gutiérrez-Aguilar R (2020) The colors of adipose tissue. Gac Med Mex 156(2):142–149. https://doi.org/10.24875/GMM.M20000356. (PMID: 32285854)CrossRefPubMed

Giordano A, Smorlesi A, Frontini A, Barbatelli G, Cinti S (2014) White, brown and pink adipocytes: the extraordinary plasticity of the adipose organ. Eur J Endocrinol 170(5):R159–R171. https://doi.org/10.1530/EJE-13-0945. (PMID: 24468979)CrossRefPubMed

Goossens GH (2017) The metabolic phenotype in obesity: fat mass, body fat distribution, and adipose tissue function. Obes Facts 10(3):207–215CrossRefPubMedPubMedCentral

Harms M, Seale P (2013) Brown and beige fat: development, function and therapeutic potential. Nat Med 19(10):1252–1263. https://doi.org/10.1038/nm.3361. (Epub 2013 Sep 29 PMID: 24100998)CrossRefPubMed

Heaton GM, Wagenvoord RJ, Kemp A Jr, Nicholls DG (1978) Brown-adipose-tissue mitochondria: photoaffinity labelling of the regulatory site of energy dissipation. Eur J Biochem 82(2):515–521CrossRefPubMed

Jeremic N, Chaturvedi P, Tyagi SC (2017) Browning of white fat: novel insight into factors, mechanisms, and therapeutics. J Cell Physiol 232(1):61–68CrossRefPubMed

Jing X, Wu J, Dong C, Gao J, Seki T, Kim C, Urgard E, Hosaka K, Yang Y, Long S, Huang P, Zheng J, Szekely L, Zhang Y, Tao W, Coquet J, Ge M, Chen Y, Adner M, Cao Y (2022) COVID-19 instigates adipose browning and atrophy through VEGF in small mammals. Nat Metab 4:1674CrossRef

Karkhut SM, Muzyka I, Savytska M, Dzhyoieva K, Pohoretska Y, Ivanchenko N, Szabo S (2021) Physiological predictors of long-term effects of COVID-19 in patients with SARS-CoV-2: focus on lymphocyte proliferation-improving micronutrients. Proceeding of the Shevchenko scientific society. Med Sci. https://doi.org/10.2504/ntsh2021.02.06CrossRef

Krams IA, Luoto S, Rantala MJ, Jõers P, Krama T (2020) Covid-19: fat, obesity, inflammation, ethnicity, and sex differences. Pathogens 9(11):887CrossRefPubMedPubMedCentral

Kruglikov IL, Scherer PE (2020) The Role of adipocytes and adipocyte-like cells in the severity of COVID-19 infections. Obesity (silver Spring) 28(7):1187–1190. https://doi.org/10.1002/oby.22856CrossRefPubMed

Landecho MF, Marin-Oto M, Recalde-Zamacona B, Bilbao I, Frühbeck G (2021) Obesity as an adipose tissue dysfunction disease and a risk factor for infections–Covid-19 as a case study. Eur J Intern Med 1(91):3–9CrossRef

Li H, Du S, Niu P, Gu X, Wang J, Zhao Y (2021) Vascular adhesion Protein-1 (VAP-1)/Semicarbazide-sensitive amine oxidase (SSAO): a potential therapeutic target for atherosclerotic cardiovascular diseases. Front Pharmacol 12:1748

Loosen SH, Jensen BEO, Tanislav C, Luedde T, Roderburg C, Kostev K (2022) Obesity and lipid metabolism disorders determine the risk for development of long COVID syndrome: a cross-sectional study from 50,402 COVID-19 patients. Infection 50:1165–1170. https://doi.org/10.1007/s15010-022-01784-0CrossRefPubMedPubMedCentral

Magyar K, Mészáros Z (2003) Semicarbazide-sensitive amine oxidase (SSAO): present and future. Inflammopharmacology 11:165–173CrossRefPubMed

Marlatt KL, Ravussin E (2017) Brown adipose tissue: an update on recent findings. Curr Obes Rep 6(4):389–396. https://doi.org/10.1007/s13679-017-0283-6CrossRefPubMedPubMedCentral

Morigny P, Houssier M, Mouisel E, Langin D (2016) Adipocyte lipolysis and insulin resistance. Biochimie 125:259–266CrossRefPubMed

Pannecoeck R, Serruys D, Benmeridja L, Delanghe JR, Geel NV, Speeckaert R, Speeckaert MM (2015) Vascular adhesion protein-1: role in human pathology and application as a biomarker. Crit Rev Clin Lab Sci 52(6):284–300CrossRefPubMed

Rada P, González-Rodríguez Á, García-Monzón C, Valverde ÁM (2020) Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver? Cell Death Dis 11(9):1–15CrossRef

Reese JT, Blau H, Casiraghi E, Bergquist T, Loomba JJ, Callahan TJ, Divers J (2023) Generalisable long COVID subtypes: findings from the NIH N3C and RECOVER programmes. EBioMedicine 87:104413CrossRefPubMed

Revenko O, Zaichko N, Wallace J, Zayachkivska O (2018) Hydrogen sulfide system attenuates injury by hyperglycemia and stress: role of mesenteric adipocytes in aged animals. Proceeding of the Shevchenko scientific society. Med Sci 54(2):115–124

Revenko O, Pavlovskiy Y, Savytska M, Yashchenko A, Kovalyshyn V, Chelpanova I, Varyvoda O, Zayachkivska O (2021) Hydrogen sulfide prevents mesenteric adipose tissue damage, endothelial dysfunction, and redox imbalance from high fructose diet-induced injury in aged rats. Front Pharmacol. https://doi.org/10.3389/fphar.2021.693100CrossRefPubMedPubMedCentral

Ricquier D, Bouillaud F (2000) Mitochondrial uncoupling proteins: from mitochondria to the regulation of energy balance. J Physiol 529(1):3–10CrossRefPubMedPubMedCentral

Ruderman NB, Schneider SH, Berchtold P (1981) The “metabolically-obese”, normal-weight individual. Am J Clin Nutr 34(8):1617–1621CrossRefPubMed

Sattar N, McInnes IB, McMurray JJ (2020) Obesity is a risk factor for severe COVID-19 infection: multiple potential mechanisms. Circulation 142(1):4–6CrossRefPubMed

Selye H, Timiras PS (1949) Participation of ‘brown fat’tissue in the alarm reaction. Nature 164(4174):745–746CrossRefPubMed

Shimizu I, Walsh K (2015) The whitening of brown fat and its implications for weight management in obesity. Curr Obes Rep 4(2):224–229. https://doi.org/10.1007/s13679-015-0157-8. (PMID: 26627217)CrossRefPubMed

Stefan N (2023) SARS-CoV-2 fires up inflammation in adipose tissue. Nat Rev Endocrinol 19:8–9. https://doi.org/10.1038/s41574-022-00778-0CrossRefPubMed

Tchkonia T, Morbeck DE, Von Zglinicki T, Van Deursen J, Lustgarten J, Scrable H, Kirkland JL (2010) Fat tissue, aging, and cellular senescence. Aging Cell 9(5):667–684. https://doi.org/10.1111/j.1474-9726.2010.00608.xCrossRefPubMed

Wang SH, Yu TY, Tsai FC, Weston CJ, Lin MS, Hung CS, Kao HL, Li YI, Solé M, Unzeta M, Chen YL (2018) Inhibition of semicarbazide-sensitive amine oxidase reduces atherosclerosis in apolipoprotein E-deficient mice. Transl Res 1(197):12–31CrossRef

World Health Organization. First-ever global coverage targets for diabetes adopted at the 75th World Health Assembly. (2022). https://www.who.int/news-room/feature-stories/detail/first-ever-global-coverage-targets-for-diabetes-adopted-at-the-75-th-world-health-assembly#:~:text=First-ever%20global%20coverage%20targets%20for%20diabetes%20adopted%20at,diabetes%20responses%20within%20national%20noncommunicable%20disease%20%28NCD%29%20programmes

Zdrojewicz Z, Popowicz E, Szyca M, Michalik T, Śmieszniak B (2017) TOFI phenotype–its effect on the occurrence of diabetes. Pediatric Endocrinol Diabetes Metab 23(2):96-100. https://doi.org/10.18544/PEDM-23.02.0079. PMID: 29073292.CrossRef

Titel: What is the role of brown adipose tissue in metabolic health: lessons learned and future perspectives in the long COVID?
verfasst von: Iryna Muzyka
Oleh Revenko
Iryna Kovalchuk
Maryanna Savytska
Anna Bekesevych
Roksolana Kasko
Oksana Zayachkivska
Publikationsdatum: 25.03.2023
Verlag: Springer International Publishing
Erschienen in: Inflammopharmacology / Ausgabe 2/2023
Print ISSN: 0925-4692
Elektronische ISSN: 1568-5608
DOI: https://doi.org/10.1007/s10787-023-01188-y

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

What is the role of brown adipose tissue in metabolic health: lessons learned and future perspectives in the long COVID?

Abstract

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2023

COVID-19-induced neurological symptoms: focus on the role of metal ions

Bioactive fraction from Plumeria obtusa L. attenuates LPS-induced acute lung injury in mice and inflammation in RAW 264.7 macrophages: LC/QToF-MS and molecular docking

A novel pharmacological mechanism of anti-cancer drugs that induce pyroptosis

Neuroprotective effect of piracetam-loaded magnetic chitosan nanoparticles against thiacloprid-induced neurotoxicity in albino rats

Long-COVID syndrome: physical–mental interplay in the spotlight

The effect of disease-modifying antirheumatic drugs (DMARDs) on bone homeostasis in rheumatoid arthritis (RA) patients